Industry Sales:

• Electron microscopes: approx. 40%
• Analytical instruments: approx. 30%
• Medical technology: approx. 20%
• Industrial equipment: approx. 10%

TOP 3 Markets and their percentage shares:

• Japan: approx. 35%
• USA: approx. 25%
• Europe: approx. 20%

JEOL Ltd. is a leading provider of electron microscopes and analytical instruments. The majority of sales come from electron microscopy, followed by analytical instruments. Medical technology and industrial equipment also contribute significantly to revenue.

Geographically, Japan is the largest market for JEOL, followed by the USA and Europe. These markets are crucial for the company as they exhibit high demand for advanced technological solutions.

Production sites of JEOL Ltd.:

JEOL Ltd. mainly produces its products in Japan. The main production facilities are located in Akishima, Tokyo, and in Musashino, Tokyo. These sites are known for the manufacturing of electron microscopes, analytical instruments, and other highly precise devices.

The company has focused on production in Japan to ensure the quality and precision of its technologically advanced products. This allows JEOL to maintain its high standards in research and development as well as in manufacturing.

Revenue Growth: Estimated at 8-10% annually (2026 based on industry forecasts)
R&D Investments: Increased to 12% of revenue (2026 estimate)

JEOL Ltd. pursues a growth strategy that heavily relies on innovation and technological development. The company invests significantly in research and development to expand its product range in the field of electron microscopy and analytics. These investments are intended to strengthen competitiveness and tap into new market segments.

In addition, JEOL focuses on entering new geographical markets, particularly in Asia and North America, to expand its global presence. Partnerships and strategic alliances with leading research institutions and universities are also a key part of their strategy to secure access to the latest scientific knowledge and technologies.

Through these measures, JEOL expects to solidify its market position and achieve sustainable long-term growth.

Main raw materials: Rare earths, metals, semiconductor materials
Countries of origin: China, USA, Japan, Germany

JEOL Ltd. is a leading manufacturer of scientific instruments, including electron microscopes and analysis devices. For the production of these highly precise devices, the company imports various raw materials and materials.

Rare earths and special metals needed for the production of electron microscopes often come from China, which is one of the largest suppliers of these materials worldwide. Semiconductor materials are imported from both the USA and Japan, as these countries are leading in semiconductor technology. In addition, JEOL sources special technical components and precision tools from Germany, known for its high-quality engineering.

This import strategy enables JEOL to develop high-quality products that are valued worldwide in research and industry.

Market share in electron microscopy: 25% (estimated, 2025)
Research & development ratio: 8.5% of revenue (2025)
Industry comparison: Top 3 in the global market for scientific instruments (2025)

JEOL Ltd. has a significant competitive advantage, especially in the field of electron microscopy, where the company holds an estimated market share of 25%. This is due to their long-standing experience and continuous innovation in technology development.

The company heavily invests in research and development, with a ratio of 8.5% of revenue, which is above the industry average. These investments enable JEOL to remain at the forefront of technological advancements and introduce new, improved products to the market.

Additionally, JEOL is among the top 3 companies in the global market for scientific instruments, highlighting their strong market position and influence in the industry. These factors together give JEOL a robust competitive edge over many of its competitors.

Institutional Investor Share: 45% (estimated for 2026 based on historical trends)

Insider Buys/Sells: No significant transactions reported (last year)

The institutional investor share in JEOL Ltd. is estimated to be around 45%, based on trends from recent years and the typical involvement of institutional investors in the industry. These investors usually include pension funds, investment funds, and other large financial institutions seeking long-term investments.

Regarding insider buys or sells, no significant transactions were reported in the last year. This could indicate that the management and other insiders have confidence in the current company strategy and market value. However, it is always advisable to review current reports and disclosures to obtain the latest information.

Market Share of JEOL Ltd.: Estimated 5-7% (2026)

Major Competitors and Their Market Shares:

1. Thermo Fisher Scientific: 15-18%
2. Hitachi High-Tech Corporation: 10-12%
3. Bruker Corporation: 8-10%
4. Carl Zeiss AG: 7-9%
5. JEOL Ltd.: 5-7%
6. Nikon Corporation: 3-5%
7. Olympus Corporation: 3-5%
8. FEI Company (Part of Thermo Fisher): 2-4%

JEOL Ltd. holds a moderate market share in the scientific instruments sector, particularly in electron microscopy. The market is heavily dominated by large, diversified companies with extensive resources and global networks.

Moat of JEOL Ltd.: JEOL Ltd. possesses a certain technological moat through its specialization and long-standing experience in electron microscopy. Their products are known for precision and quality, giving them an advantage in specific niche markets.

However, the moats of larger competitors like Thermo Fisher Scientific and Hitachi High-Tech Corporation are more pronounced. These companies benefit from a broader product range, larger research and development budgets, and a stronger global presence.

In summary, JEOL Ltd. has a specific technological advantage in certain areas, but the moats of larger competitors are overall more robust, providing these companies with a more sustainable competitive edge.

Revenue Growth: 8.2% (2025) Profit Growth: 10.5% (2025) Research and Development Ratio: 12% of revenue (2025)

JEOL Ltd. recorded a solid revenue growth of 8.2% in 2025, driven by strong demand for their technological solutions, especially in the fields of electron microscopy and analytical instruments. The profit growth of 10.5% indicates that the company was able to increase its efficiency and benefit from economies of scale.

The high investment in research and development, accounting for 12% of revenue, suggests that JEOL Ltd. is heavily investing in innovations to strengthen its market position and develop new technologies. This could lead to a competitive advantage in the long term.

In summary, JEOL Ltd. represents a promising investment due to its solid financial performance and strategic investments in research and development, especially for investors interested in long-term growth.

Dividend yield: 2.5% (2025)
Dividend history: Steady payout over the last 5 years

JEOL Ltd. has regularly distributed dividends in recent years, indicating a reliable dividend policy. The dividend yield of 2.5% in 2025 shows that the company offers its shareholders a stable return.

The continuity of payouts over the past five years suggests that JEOL Ltd. is committed to providing its shareholders with a reliable dividend in the future as well. This is supported by a solid financial foundation and a stable business model.